AstraZeneca (AZN) shares jump on much stronger Q1 top and bottom line
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
AstraZeneca (AZN) Tops Q1 EPS by 110c; reaffirms guidance
April 25, 2024 4:57 AM EDTAstraZeneca (NASDAQ: AZN) reported Q1 EPS of $2.06, $1.10 better than the analyst estimate of $0.96. Revenue for the quarter came in at $12.68 billion versus the consensus estimate of $11.79 billion.
GUIDANCE
The Company reiterates its Total Revenue and Core EPS guidance for FY 2024 at CER, based on... More
